Glenmark to wait 10 months for FDA’s approval of Oxycodone

According to Glenmark Generics, its drug Oxycodone Hydrochloride capsules and liquid solutions was applied to the US Food and Drug Administration (FDA) by their associate Lehigh Valley Technologies or LVT as new drug application or NDA. However, ten months is the waiting period for FDA’s approval.